.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Novartis
Healthtrust
Citi
QuintilesIMS
Daiichi Sankyo
Argus Health
Express Scripts
Chubb

Generated: February 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Italy Patent: MI2000A0422

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Valeant Pharms IntlUCERISbudesonideTABLET, EXTENDED RELEASE;ORAL203634-001Jan 14, 2013RXYesYes➤ Sign Up➤ Sign UpYINDUCTION OF REMISSION IN PATIENTS WITH ACTIVE, MILD TO MODERATE ULCERATIVE COLITIS
Valeant Pharms IntlUCERISbudesonideTABLET, EXTENDED RELEASE;ORAL203634-001Jan 14, 2013RXYesYes➤ Sign Up➤ Sign UpY
Valeant Pharms IntlUCERISbudesonideTABLET, EXTENDED RELEASE;ORAL203634-001Jan 14, 2013RXYesYes➤ Sign Up➤ Sign UpYINDUCTION OF REMISSION IN PATIENTS WITH ACTIVE, MILD TO MODERATE ULCERATIVE COLITIS
Valeant Pharms IntlUCERISbudesonideTABLET, EXTENDED RELEASE;ORAL203634-001Jan 14, 2013RXYesYes➤ Sign Up➤ Sign UpYINDUCTION OF REMISSION IN PATIENTS WITH ACTIVE, MILD TO MODERATE ULCERATIVE COLITIS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist